Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $21.95 million. The enterprise value is $19.20 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.60 million shares outstanding. The number of shares has increased by 1.85% in one year.
Current Share Class | 10.60M |
Shares Outstanding | 10.60M |
Shares Change (YoY) | +1.85% |
Shares Change (QoQ) | +0.57% |
Owned by Insiders (%) | 12.80% |
Owned by Institutions (%) | 44.61% |
Float | 9.24M |
Valuation Ratios
The trailing PE ratio is 27.28.
PE Ratio | 27.28 |
Forward PE | n/a |
PS Ratio | 1.41 |
Forward PS | 1.43 |
PB Ratio | 2.36 |
P/TBV Ratio | 2.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 23.97 |
EV / Sales | 1.24 |
EV / EBITDA | 21.12 |
EV / EBIT | 24.87 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.14.
Current Ratio | 5.92 |
Quick Ratio | 4.45 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.90 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.17% and return on invested capital (ROIC) is 4.71%.
Return on Equity (ROE) | 9.17% |
Return on Assets (ROA) | 4.16% |
Return on Invested Capital (ROIC) | 4.71% |
Return on Capital Employed (ROCE) | 7.52% |
Revenue Per Employee | $500,548 |
Profits Per Employee | $25,839 |
Employee Count | 31 |
Asset Turnover | 1.34 |
Inventory Turnover | 2.46 |
Taxes
In the past 12 months, Nephros has paid $15,000 in taxes.
Income Tax | 15,000 |
Effective Tax Rate | 1.84% |
Stock Price Statistics
The stock price has decreased by -1.38% in the last 52 weeks. The beta is 0.81, so Nephros's price volatility has been lower than the market average.
Beta (5Y) | 0.81 |
52-Week Price Change | -1.38% |
50-Day Moving Average | 1.79 |
200-Day Moving Average | 1.69 |
Relative Strength Index (RSI) | 58.85 |
Average Volume (20 Days) | 6,487 |
Short Selling Information
The latest short interest is 8,083, so 0.08% of the outstanding shares have been sold short.
Short Interest | 8,083 |
Short Previous Month | 11,427 |
Short % of Shares Out | 0.08% |
Short % of Float | 0.09% |
Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, Nephros had revenue of $15.52 million and earned $801,000 in profits. Earnings per share was $0.08.
Revenue | 15.52M |
Gross Profit | 9.69M |
Operating Income | 772,000 |
Pretax Income | -1.29M |
Net Income | 801,000 |
EBITDA | 909,250 |
EBIT | 772,000 |
Earnings Per Share (EPS) | $0.08 |
Full Income Statement Balance Sheet
The company has $4.08 million in cash and $1.33 million in debt, giving a net cash position of $2.75 million or $0.26 per share.
Cash & Cash Equivalents | 4.08M |
Total Debt | 1.33M |
Net Cash | 2.75M |
Net Cash Per Share | $0.26 |
Equity (Book Value) | 9.29M |
Book Value Per Share | 0.88 |
Working Capital | 7.47M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 62.45%, with operating and profit margins of 4.98% and 5.16%.
Gross Margin | 62.45% |
Operating Margin | 4.98% |
Pretax Margin | 5.26% |
Profit Margin | 5.16% |
EBITDA Margin | 5.86% |
EBIT Margin | 4.98% |
FCF Margin | n/a |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.85% |
Shareholder Yield | -1.85% |
Earnings Yield | 3.65% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Nephros is $5.00, which is 141.43% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 141.43% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 10, 2019 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -10.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -10.2 |
Piotroski F-Score | 5 |